A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 is highly metastatic in vivo
Open Access
- 6 February 2020
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-12
Abstract
Despite recent advances in melanoma treatment, metastasis and resistance to therapy remain serious clinical challenges. NME1 is a metastasis suppressor, a class of proteins which inhibits metastatic spread of cancer cells without impact on growth of the primary tumor. We have identified a rare subpopulation of cells with markedly reduced expression of NME1 (NME1LOW) in human melanoma cell lines. To enable isolation of viable NME1LOW cells for phenotypic analysis by fluorescence-activated cell sorting (FACS), a CRISPR-Cas9-mediated approach was used to attach an EGFP coding module to the C-terminus of the endogenous NME1 gene in melanoma cell lines. NME1LOW cells displayed enhanced collective invasion in vitro when implanted as 3D aggregates in Matrigel. NME1LOW cells were also highly metastatic to lung and liver when xenografted subcutaneously in immune-deficient NSG mice. RNA-seq analysis revealed that NME1LOW cells express elevated levels of genes associated with tumor aggressiveness, as well as with morphogenesis of tissues of neural crest-like origin (melanocytes and neurons, bone and heart tissues; GO: 0009653). The highly malignant NME1LOW variant of melanoma cells has potential to provide novel therapeutic targets and molecular markers for improved clinical management of patients with advanced melanoma.Keywords
Funding Information
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA83237, CA159871, MD)
- U.S. Department of Health & Human Services | NIH | National Cancer Institute
- U.S. Department of Health & Human Services | NIH | National Cancer Institute
- U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM055036)
- Maryland Stem Cell Foundation MSCRFI-1638
This publication has 43 references indexed in Scilit:
- Minimal functional driver gene heterogeneity among untreated metastasesScience, 2018
- Melanoma treatment in reviewImmunoTargets and Therapy, 2018
- Intratumor and Intertumor Heterogeneity in MelanomaTranslational Oncology, 2017
- Tumour Heterogeneity: The Key Advantages of Single-Cell AnalysisInternational Journal of Molecular Sciences, 2016
- Commentary on “Tumor Heterogeneity and the Biology of Cancer Invasion and Metastasis”Cancer Research, 2016
- Dual functions of NME1 in suppression of cell motility and enhancement of genomic stability in melanomaNaunyn-Schmiedeberg's Archives of Pharmacology, 2014
- Thinking outside the box: Using metastasis suppressors as molecular toolsSeminars in Cancer Biology, 2011
- Tumor heterogeneity: Causes and consequencesBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2010
- Heterogeneity in Cancer: Cancer Stem Cells versus Clonal EvolutionCell, 2009
- Evidence for a Novel Gene Associated With Low Tumor Metastatic PotentialJNCI: Journal of the National Cancer Institute, 1988